FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938182820> ?p ?o ?g. }

• W2938182820 endingPage "e636" @default.
• W2938182820 startingPage "e624" @default.
• W2938182820 abstract "5-alpha reductase inhibitors (5ARIs) decrease the androgen levels in vivo and are currently used for the treatment of benign prostatic hyperplasia (BPH) in men. However, these inhibitors can also increase the risk of gynecomastia, breast tenderness, and breast cancer. Hence, we did a systematic review and meta-analysis to evaluate the rate of breast-related diseases in men treated with 5ARIs.PubMed, Embase, Cochrane, and CNKI databases were searched for randomized controlled trials using 5ARIs in patients with BPH. Data were analyzed by using Cochrane Collaboration review manager program and Stata 12.0 software.In total, 14 studies were included in the meta-analysis. Gynecomastia was significantly more common with 5ARIs treatment when compared with placebo (3.30% vs. 1.84%; P < .00001) or alpha blockers (ABs) monotherapy (2.33% vs. 1.00%; P = .0009). Both dutasteride (2.03% vs. 0.90%; P < .00001) and finasteride (4.08% vs. 2.43%; P < .00001) are associated with significantly higher risk of gynecomastia than placebo. Risk for breast tenderness was elevated in 5ARIs users (0.83% vs. 0.25%; P = .01) or in users having combination therapy with ABs (2.48% vs. 0.58%; P < .0001). Finasteride is associated with significantly higher risk of breast tenderness than placebo (0.80% vs. 0.25%; P = .02).In male patients with BPH, 5ARIs have significantly increased the risk of gynecomastia and breast tenderness but may be not to the breast cancer. In addition, combination therapy is significantly associated with higher risk of breast tenderness compared to single ABs monotherapy." @default.
• W2938182820 created "2019-04-25" @default.
• W2938182820 creator A5006180330 @default.
• W2938182820 creator A5024010994 @default.
• W2938182820 creator A5038259876 @default.
• W2938182820 creator A5041712105 @default.
• W2938182820 date "2019-10-01" @default.
• W2938182820 modified "2023-10-01" @default.
• W2938182820 title "Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia" @default.
• W2938182820 cites W107210901 @default.
• W2938182820 cites W1158428179 @default.
• W2938182820 cites W1545422145 @default.
• W2938182820 cites W1558621919 @default.
• W2938182820 cites W1580447354 @default.
• W2938182820 cites W1729580440 @default.
• W2938182820 cites W1801847806 @default.
• W2938182820 cites W1925520630 @default.
• W2938182820 cites W1964361574 @default.
• W2938182820 cites W1964435302 @default.
• W2938182820 cites W1986693832 @default.
• W2938182820 cites W1992773110 @default.
• W2938182820 cites W1993339135 @default.
• W2938182820 cites W2009611361 @default.
• W2938182820 cites W2027553002 @default.
• W2938182820 cites W2031083181 @default.
• W2938182820 cites W2033585778 @default.
• W2938182820 cites W2034836973 @default.
• W2938182820 cites W2051592657 @default.
• W2938182820 cites W2057761968 @default.
• W2938182820 cites W2074536439 @default.
• W2938182820 cites W2094825611 @default.
• W2938182820 cites W2106349605 @default.
• W2938182820 cites W2121759271 @default.
• W2938182820 cites W2126448053 @default.
• W2938182820 cites W2140350291 @default.
• W2938182820 cites W2149050381 @default.
• W2938182820 cites W2155530804 @default.
• W2938182820 cites W2162405033 @default.
• W2938182820 cites W2549274478 @default.
• W2938182820 cites W2587347639 @default.
• W2938182820 cites W2607763466 @default.
• W2938182820 cites W2773325120 @default.
• W2938182820 cites W2804551733 @default.
• W2938182820 cites W2065058117 @default.
• W2938182820 cites W2133929387 @default.
• W2938182820 doi "https://doi.org/10.1016/j.clbc.2019.04.006" @default.
• W2938182820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31126837" @default.
• W2938182820 hasPublicationYear "2019" @default.
• W2938182820 type Work @default.
• W2938182820 sameAs 2938182820 @default.
• W2938182820 citedByCount "1" @default.
• W2938182820 countsByYear W29381828202022 @default.
• W2938182820 crossrefType "journal-article" @default.
• W2938182820 hasAuthorship W2938182820A5006180330 @default.
• W2938182820 hasAuthorship W2938182820A5024010994 @default.
• W2938182820 hasAuthorship W2938182820A5038259876 @default.
• W2938182820 hasAuthorship W2938182820A5041712105 @default.
• W2938182820 hasConcept C121608353 @default.
• W2938182820 hasConcept C126322002 @default.
• W2938182820 hasConcept C126894567 @default.
• W2938182820 hasConcept C141071460 @default.
• W2938182820 hasConcept C142724271 @default.
• W2938182820 hasConcept C204787440 @default.
• W2938182820 hasConcept C27081682 @default.
• W2938182820 hasConcept C2775874879 @default.
• W2938182820 hasConcept C2776235491 @default.
• W2938182820 hasConcept C2777562237 @default.
• W2938182820 hasConcept C2777691561 @default.
• W2938182820 hasConcept C2778878792 @default.
• W2938182820 hasConcept C2780003869 @default.
• W2938182820 hasConcept C2780192828 @default.
• W2938182820 hasConcept C2910366748 @default.
• W2938182820 hasConcept C530470458 @default.
• W2938182820 hasConcept C71924100 @default.
• W2938182820 hasConceptScore W2938182820C121608353 @default.
• W2938182820 hasConceptScore W2938182820C126322002 @default.
• W2938182820 hasConceptScore W2938182820C126894567 @default.
• W2938182820 hasConceptScore W2938182820C141071460 @default.
• W2938182820 hasConceptScore W2938182820C142724271 @default.
• W2938182820 hasConceptScore W2938182820C204787440 @default.
• W2938182820 hasConceptScore W2938182820C27081682 @default.
• W2938182820 hasConceptScore W2938182820C2775874879 @default.
• W2938182820 hasConceptScore W2938182820C2776235491 @default.
• W2938182820 hasConceptScore W2938182820C2777562237 @default.
• W2938182820 hasConceptScore W2938182820C2777691561 @default.
• W2938182820 hasConceptScore W2938182820C2778878792 @default.
• W2938182820 hasConceptScore W2938182820C2780003869 @default.
• W2938182820 hasConceptScore W2938182820C2780192828 @default.
• W2938182820 hasConceptScore W2938182820C2910366748 @default.
• W2938182820 hasConceptScore W2938182820C530470458 @default.
• W2938182820 hasConceptScore W2938182820C71924100 @default.
• W2938182820 hasIssue "5" @default.
• W2938182820 hasLocation W29381828201 @default.
• W2938182820 hasLocation W29381828202 @default.
• W2938182820 hasOpenAccess W2938182820 @default.
• W2938182820 hasPrimaryLocation W29381828201 @default.
• W2938182820 hasRelatedWork W1964928662 @default.
• W2938182820 hasRelatedWork W2009744625 @default.

• next